The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?
Saved in:
Main Authors: | Iván Peñuelas (Author), Daniëlle J. Vugts (Author), Clemens Decristoforo (Author), Philip H. Elsinga (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Are we "preparing" radiopharmaceuticals?
by: Clemens Decristoforo, et al.
Published: (2016) -
US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations
by: Sally W. Schwarz, et al.
Published: (2019) -
Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023)
by: Amirreza Jalilian, et al.
Published: (2023) -
EANM guideline on the validation of analytical methods for radiopharmaceuticals
by: Nic Gillings, et al.
Published: (2020) -
Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals
by: J. Koziorowski, et al.
Published: (2016)